Cargando…

Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery

BACKGROUND: HLA-DR+ T cell, accounting for 1.2%–5.8% of peripheral lymphocyte, is a type of activated T lymphocyte. This retrospective study aimed to evaluate the prognostic value of HLA-DR+ T cell for progression-free survival (PFS) and overall survival (OS) in hepatocellular carcinoma (HCC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Rui-Qian, Sun, Jing-Han, Ma, Yong-Hui, Xie, Yu-Wei, Shao, Guan-Ming, Wang, Cong, Tan, Bin, Liu, Kui, Li, Kun, Li, Na, Hu, Wei-Yu, Cao, Jingyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981292/ https://www.ncbi.nlm.nih.gov/pubmed/36873738 http://dx.doi.org/10.1155/2023/1875153

Ejemplares similares

Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection
por: Wu, Jiong, et al.
Publicado: (2017)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
por: Xu, Wei, et al.
Publicado: (2020)

Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report
por: Liao, Rui, et al.
Publicado: (2015)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy
por: Shen, Xueqin, et al.
Publicado: (2021)

Factors influencing early recurrence of hepatocellular carcinoma after curative resection
por: Zhu, Yu, et al.
Publicado: (2020)

Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ni, Hang-Hang, et al.
Publicado: (2022)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy
por: Xia, Wuzheng, et al.
Publicado: (2021)

Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection
por: Li, Guang-Jun, et al.
Publicado: (2017)

Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation
por: Zhang, Ling, et al.
Publicado: (2021)

Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection
por: Qu, Zhen, et al.
Publicado: (2022)

A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR)
por: Shen, Junyi, et al.
Publicado: (2019)

Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection
por: Byeon, Jangmoo, et al.
Publicado: (2012)

Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram
por: Yuan, Chunwang, et al.
Publicado: (2019)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy
por: Soong, Ruey-Shyang, et al.
Publicado: (2011)

Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection
por: Zhou, Yan-Ming, et al.
Publicado: (2015)

Impact of prognostic nutritional index on the recurrence of hepatocellular carcinoma after a curative resection
por: Jeong, Ho, et al.
Publicado: (2021)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
por: Choi, Woo Jin, et al.
Publicado: (2023)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
por: Huang, Gui-Qian, et al.
Publicado: (2017)

Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation
por: Jung, Hee-Yeon, et al.
Publicado: (2017)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
por: Ma, Hui, et al.
Publicado: (2021)

Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection
por: Adwan, Hamzah, et al.
Publicado: (2023)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy
por: Wu, YiFeng, et al.
Publicado: (2021)

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection()
por: Liao, Weijia, et al.
Publicado: (2014)

Prognostic Significance of Platelet-to-Lymphocyte Ratio (PLR) in Extrahepatic Metastasis of Hepatocellular Carcinoma After Curative Resection
por: Chen, Yifan, et al.
Publicado: (2021)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy
por: Lee, Chern-Horng, et al.
Publicado: (2023)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
por: Wu, Huang-Pin, et al.
Publicado: (2022)

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study
por: Gan, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_25mek89gnqrcoim6hca1almcd1